Abstract OBJECTIVE: The purpose of this study was to establish the safety and feasibility of a recently adopted policy to type and screen (TS) (group and save) only for selected patients who had low likelihood of transfusion requirement.
INTRODUCTION
A number of previous studies have shown that perioperative blood transfusion increases the risks of infection, systemic inflammatory response syndrome, multiple organ failure and mortality [1, 2] . Additionally, there is concern that immunomodulation combined with the decreased natural killer cell activity seen during the perioperative period may support tumour growth and compromise the long-term survival of transfused cancer patients [3] [4] [5] . There is no clear guideline on whether and how many units of blood should be kept cross matched and ready for patients undergoing lobectomy for any indication [6, 7] .
Thoracic surgery services in Greater Manchester have lately undergone significant changes including centralization of surgery at University Hospital of South Manchester. To improve the quality of services at UHSM, a number of organizational and policy changes have been introduced. One of these changes has been a reduction of the units of blood cross matched for patients undergoing elective major lung resections. The standard practice in the majority of thoracic surgical units in the UK (verbal communication) including ours is to routinely cross match two units of blood for all patients undergoing elective lobectomy. We recently introduced a new policy of type and screen (group and save) only for patients who had low likelihood of perioperative transfusion requirement. This study was designed to establish the safety and feasibility of this new policy.
MATERIALS AND METHODS
Type and screen (TS) only policy was applied to patients undergoing first-time elective lobectomy for benign or malignant indication if they were deemed to be low risk for bleeding based on predefined inclusion/exclusion criteria agreed by all the clinicians involved, as given in Table 1 . The patients deemed to be at low risk were those undergoing first-time elective lobectomy with preoperative haemoglobin (Hb) of >11 g/dl, aged <70 years, with no clotting abnormality, no abnormal antibodies and no history of neoadjuvant therapy. When the blood bank has TS data already available, they are able to make an electronic issue of blood units in a short time period of 5-10 min. However, there was concern about the variability in time interval required for collection of blood from the blood bank and delivery to the theatre by portering services. Delivery time tends to vary enormously depending on availability of man power, the number of demands placed and time of the day. To avoid the risk of excessive delay due to these reasons, a provision was made for regular storage of two units of O negative blood at all times in theatre to cover any emergencies. Besides this, UHSM has a massive haemorrhage protocol in operation for any incidence of massive bleeding in any patients in the hospital.
We identified the patients undergoing elective lobectomies from our unit thoracic surgery clinical database during the study period from November 2009 to October 2010. A total of 208 consecutive patients underwent elective lobectomy during this time. Blood bank data showed that TS only policy was applied to 87 patients who met the criteria (Group TS, n = 87), while preoperative cross matching (XM) (Group XM, n = 121) was required in 121 patients who did not meet the criteria. Clinical data were obtained from the case notes. The perioperative characteristics, transfusion requirements and outcomes were compared between the two groups. Continuous data were compared using Student's t-tests and categorical data were compared using χ 2 tests employing the SPSS statistical software.
RESULTS
As expected, the XM group were significantly older (mean 62 vs 67 years, P = 0.007), with lower mean preoperative Hb levels (13.7 vs 12.96, P = 0.01) ( Table 2 ). They were similar in all other preoperative variables such as gender, malignancy, respiratory comorbidity, diabetes etc. Anatomical details of the surgical resection carried out in terms of single lobe or bilobectomy were similar, as given in Table 3 . Respiratory complications in the form of prolonged air leak/pneumonia/pleural collection/respiratory failure were the commonest complications. The incidence of this in the type and screen group, of 9% (7/81) was similar to that in the cross match group, of 13% (16/121), P = 0.24. Other complications were also similar between the two groups. The median hospital stay in days (inter-quartile range) were XM 6(IQR 5-9 days) and TS 5(IQR 4-7.5 days), respectively, which was significantly longer in the former group (P = 0.04). The in-hospital mortality, however, was similar between the two groups [0% (0/87) and 0.8% (1/121) in TS and XM, respectively,
Patients were transfused if their postoperative Hb levels were <9 g/dl or when they were deemed to need blood transfusion on clinical judgement. On the day of operation, 16 patients (13%) required transfusion in the XM group. Six patients in the TS group required XM, of which only 3 (3.4%) actually required transfusion (P = 0.02). A total of 288 units were cross matched in the XM group, of which 28 units were transfused and the remaining 260 units were returned to the blood bank from the theatre. No blood units were required to be returned in the TS group. When blood was required, it was made available at the time of clinical need without undue delays. No patient required emergency transfusion of O negative blood kept on stand by in the theatre. The mean postoperative Hb levels in the XM group were also significantly lower (12.96 vs 10.88 gm/dl).
Because of the very small number of patients actually receiving transfusion, it was not possible to make any meaningful statistical comparison between the transfused patients in the two groups in terms of diagnosis, tumour size and nodal staging (Table 4 ). In the majority of cases, the triggers for transfusion were blood loss due to the presence of adhesions, lung fragility, nodal encasement of vessels or tumour extent. Two of the patients in the XM group were transfused due to active bleeding. The first patient had bleeding from a pulmonary arterial branch during a video-assisted thoracoscopic lobectomy, requiring conversion. The second patient had a left lower lobectomy following a previous CABG involving wide opening of pleura for left internal thoracic artery harvesting. There was bleeding from an injury to right ventricular outflow tract requiring suture control.
Where we anticipated the dissection to be bloody and difficulty at the time of assessment, a prior cross match was performed and those patients were entered into the XM group.
DISCUSSION
The adverse impact of transfusion on the outcomes of major thoracic surgery has been well publicized in a number of previous studies. However, there are no data available on this issue in the thoracic surgery literature. A number of reports from other disciplines of surgery and anaesthesia have investigated the TS only policy. Evidence from these studies has suggested that TS alone is satisfactory for procedures with a mean transfusion rate of <0.50 erythrocyte units per patient [8] .
van Klei et al. [9] categorized the surgical procedures into three groups based on the risk of transfusion: low-risk procedures (risk of transfusion 0-1%, e.g. ear surgery or arthroscopy), intermediate-risk procedures (risk of transfusion 1-30%, e.g. cholecystectomy and hysterectomy) and high-risk procedures (risk >30% e.g. aortic surgery). Their policy was no test including TS for the low-risk group, TS only for the intermediate-risk group and XM for the high-risk group. Among the intermediate-risk group, they showed that factors predictive of transfusion needs were female gender, age > 70 and type of surgery. They suggested that TS only should be performed for procedures with ≥5% incidence of transfusion with one or more units, but none of these procedures included pulmonary lobectomy. Mann et al. [10] studied patients undergoing elective endovascular aortic aneurysm repair (EVAR) and found that the incidence of transfusion was 1% intraoperatively and overall 6% for the entire hospital stay. The EVAR patients had a cross match to transfusion ratio of 11:1. Based on this, they concluded TS only was recommended for elective EVAR procedures. A number of other articles pertaining to general surgery [11] , neurosurgery [12] and breast surgery [13] have recommended that even TS can be avoided altogether.
A TS only policy has a number of advantages compared with routine XM. XM blood for all patients is wasteful of resources. For the blood bank, it can make a significant saving in terms of time and resources, allowing a smoother operation with a lower level of bloodstock. It also saves the portering cost of delivering and collecting blood units to and from the blood bank. Handling of blood requires at least a few minutes of time spent in checking, crosschecking and recording by the theatre staff when arriving and leaving the theatre or blood bank. However, the financial cost of the time spent by staff and porters in handling and transporting blood units was difficult to calculate. Additionally, TS prolongs the shelf life of blood by avoiding a period of inactive storage time in the theatre fridge. The policy is also likely to have an influence on the behaviour of clinicians involved in encouraging reduced usage of blood and blood products.
The limitation of our study is the relatively small sample size, and observational nature of study with no prospective randomization or matching of groups. Any prospective matching would ideally require that only the low-risk patients are selected and divided into TS and XM groups and compared for the study. That means we will need to continue to perform routine XM in THORACIC a number of low-transfusion-risk patients. Based on our study, this seems to be against the best medical practice and will be difficult to justify. However, the safety and feasibility of the TS only policy in selected patients has been clearly established. Our study is the first thoracic surgical paper to look at this policy and makes a valuable contribution to thoracic surgical literature. Preoperative differences between the two groups were as expected from the exclusion criteria. The XM group had included older patients with lower Hb resulting in higher usage of blood transfusion in the XM group. This study shows that the criteria we used for the safe selection of patients for the TS only policy are satisfactory. The study suggests that routine XM for all patients undergoing elective lobectomy is unnecessary and TS only is safe for selected patients with lower risk of bleeding. The policy also confers economic benefit to the institutions. We are encouraged by the findings of this study and plan to extend this to other operative procedures in future.
APPENDIX. CONFERENCE DISCUSSION
Dr A. Ooi (Tai Seng, Singapore): I just want to ask whether in any of your group and save patients, were any of the procedures a VATS lobectomy? And the second question is, if on the day of operation one of the team members found out that unfortunately there was no O group blood standby available, would you still go ahead with the procedure?
Dr Devbhandari: I couldn't understand the second question. Dr Ooi: You said that in the group and save, as a safety measure you always have two units of group O blood on standby; do you always routinely check that on the morning of operation there are really two units of O blood on standby?
Dr Devbhandari: That is correct, we keep two units of blood crossmatched and that is routinely checked every day, and, fortunately, we didn't have to use any of those two units throughout this study period. Coming to the question of VATS, yes, some of the patients were VATS, but the number of patients undergoing VATS in either group was not significantly different.
Dr Ooi: Patients undergoing VATS lobectomy? Dr Devbhandari: Yes, some of the patients were. Dr Ooi: Okay. The group and save policy is presumably safe even for VATS lobectomy patients?
Dr Devbhandari: Yes, that's correct. Dr F. Sollitto (Foggia, Italy): How do you consider the patient with liver disease, in which group do you consider them?
Dr Devbhandari: Any patient who has any suspicion of coagulation disorder, including liver disease, we rule out from group and save only policy.
Dr. P. Kestenholz (Zurich, Switzerland): How many of your patients had only one blood transfusion unit?
Dr Devbhandari: I think two of the patients had transfusions of only one unit each.
Dr R. Santosham (Chennai, India): I think it is basically the type of disease also that you see in the West when compared to the type of disease we see in a country like India. I would never be comfortable not having at least one or two units of blood, because sometimes when the pulmonary vessels bleed, you are in deep trouble, and I would not be comfortable. I would like to ask the people in the house, how many of you would be comfortable in not having blood in the theatre or cross-matched and ready before contemplating a case? Can you raise hands?
(Show of hands). Dr Santosham: I think the majority are wanting to have blood ready. I think it depends upon the place where you work and the type of diseases that you see. I think that is about it.
